Mean resistance time to ensidipine

Enasidenib is used to treat adults with IDH2-mutated acute myeloid leukemia (AML) who have relapsed or have not improved with prior treatment. Ensidipine may also be used for purposes not listed in this Medication Guide. The average time to resistance to ensidipine varies among individuals and depends on a variety of factors, including the patient's genetic variation, leukemia subtype, and overall health status. Therefore, an exact mean time to resistance cannot be given.

Some studies suggest that resistance may develop over months to years of treatment. However, this is only a generalization and specifics may vary based on individual patient differences. In order to prolong the drug resistance time, it is recommended to follow the doctor's instructions and take the medicine on time when using ensidipine. At the same time, pay attention to maintaining a healthy lifestyle, such as a balanced diet, moderate exercise, and avoiding smoking and drinking. In addition, regular review and monitoring, as well as timely adjustment of treatment plans, can also help prolong the duration of drug resistance.

Encidipine research medicine is not currently on the market in China, so it cannot be included in medical insurance. The price of ensidipine plain medicine when it is launched overseas is very high, and the price of each box may be around 30,000 yuan (the price may fluctuate due to the exchange rate). Currently, there are cheaper generic ensidipine drugs produced by other pharmaceutical companies overseas. For example, the price of Specification50mg*30 tablets produced by a Laos pharmaceutical factory may be more than 2,000 yuan per box (the price may fluctuate due to the exchange rate). Its pharmaceutical ingredients are basically the same as those of the original drugs sold abroad. For more information on overseas drug prices and specific information, please consult Yaode Medical Consultant.